• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383556
Medical Device Problem Code Device Contamination with Chemical or Other Material (2944)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/10/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
It was reported that bd nexiva sp with maxzero foreign matter on catheter.The following information was provided by the initial reporter: flexible plastic catheter portion of nexiva 20g intra venous observed to have visible defect / debris left on outside of catheter.Lot: 4178020.Customer response received on 03-feb-2025.The defect was observed before the product was used for patient care, so there was no harm or negative outcome.
 
Additional Manufacturer Narrative
Investigation results: the complaint of unintended material on the iv catheter was confirmed; however, the composition and source of the material could not be determined due to the condition of the returned sample.One 20g nexiva device was received in open packaging.A clear material was observed on the external surface of the iv catheter tubing.As it was reported that the material was on the catheter, the material was sent for analysis, but the analysis was inconclusive, and no definitive match was made.Due to the sample condition, it could not be confirmed when or how the material was introduced.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.The bd business team regularly reviews the collected data for identification of emerging trends.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Event or Problem Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA SP WITH MAXZERO
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key21406766
Report Number1710034-2025-00256
Device Sequence Number12892620
Product Code FOZ
UDI-Device Identifier00382903835560
UDI-Public(01)00382903835560(11)240703(17)270630(10)4178020
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 03/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number383556
Device Lot Number4178020
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/07/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/31/2025
Supplement Date Received by Manufacturer03/20/2025
Initial Report FDA Received Date02/18/2025
Supplement Report FDA Received Date03/20/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/03/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-